Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts
- PMID: 34021573
- DOI: 10.1177/2047487320909065
Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts
Abstract
Aims: The association between caffeinated coffee consumption and atrial fibrillation remains unclear. Recent studies suggest an inverse association only between a moderate caffeinated coffee consumption and atrial fibrillation, but others have reported no association. The aim of our study was to prospectively assess the association between caffeinated coffee consumption and atrial fibrillation in two Spanish cohorts, one of adults from a general population and another of elderly participants at high cardiovascular risk.
Methods and results: We included 18,983 and 6479 participants from the 'Seguimiento Universidad de Navarra' (SUN) and 'Prevención con Dieta Mediterránea' (PREDIMED) cohorts, respectively. Participants were classified according to their caffeinated coffee consumption in three groups: ≤3 cups/month, 1-7 cups/week, and >1 cup/day. We identified 97 atrial fibrillation cases after a median follow-up of 10.3 years (interquartile range 6.5-13.5), in the SUN cohort and 250 cases after 4.4 years median follow-up (interquartile range 2.8-5.8) in the PREDIMED study. No significant associations were observed in the SUN cohort although a J-shaped association was suggested. A significant inverse association between the intermediate category of caffeinated coffee consumption (1-7 cups/week) and atrial fibrillation was observed in PREDIMED participants with a multivariable-adjusted hazard ratio = 0.53 (95% confidence interval 0.36-0.79) when compared with participants who did not consume caffeinated coffee or did it only occasionally. No association was found for higher levels of caffeinated coffee consumption (>1 cup per day), hazard ratio = 0.79 (95% confidence interval 0.49-1.28). In the meta-analysis of both PREDIMED and SUN studies, the hazard ratio for intermediate consumption of caffeinated coffee was 0.60 (95% confidence interval 0.44-0.82) without evidence of heterogeneity. Similar findings were found for the association between caffeine intake and atrial fibrillation risk.
Conclusion: Intermediate levels of caffeinated coffee consumption (1-7 cups/week) were associated with a reduction in atrial fibrillation risk in two prospective Mediterranean cohorts.
Trial registration: ClinicalTrials.gov NCT02669602.
Keywords: Atrial fibrillation; Mediterranean diet; caffeine; coffee.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose-Response Meta-Analysis of Prospective Studies.Front Cardiovasc Med. 2022 Jul 6;9:894664. doi: 10.3389/fcvm.2022.894664. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35872898 Free PMC article.
-
Coffee Consumption and the Risk of Metabolic Syndrome in the 'Seguimiento Universidad de Navarra' Project.Antioxidants (Basel). 2023 Mar 10;12(3):686. doi: 10.3390/antiox12030686. Antioxidants (Basel). 2023. PMID: 36978934 Free PMC article.
-
Extravirgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevención con Dieta Mediterránea) trial.Circulation. 2014 Jul 1;130(1):18-26. doi: 10.1161/CIRCULATIONAHA.113.006921. Epub 2014 Apr 30. Circulation. 2014. PMID: 24787471 Clinical Trial.
-
Coffee Consumption and Risk of Atrial Fibrillation in the Physicians' Health Study.J Am Heart Assoc. 2019 Aug 6;8(15):e011346. doi: 10.1161/JAHA.118.011346. Epub 2019 Aug 5. J Am Heart Assoc. 2019. PMID: 31378120 Free PMC article.
-
Caffeinated and decaffeinated coffee consumption and risk of all-cause mortality: a dose-response meta-analysis of cohort studies.J Hum Nutr Diet. 2019 Jun;32(3):279-287. doi: 10.1111/jhn.12633. Epub 2019 Feb 20. J Hum Nutr Diet. 2019. PMID: 30786114
Cited by
-
Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose-Response Meta-Analysis of Prospective Studies.Front Cardiovasc Med. 2022 Jul 6;9:894664. doi: 10.3389/fcvm.2022.894664. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35872898 Free PMC article.
-
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25. Circulation. 2023. PMID: 36695182 Free PMC article. Review.
-
A Remote Nutritional Intervention to Change the Dietary Habits of Patients Undergoing Ablation of Atrial Fibrillation: Randomized Controlled Trial.J Med Internet Res. 2020 Dec 7;22(12):e21436. doi: 10.2196/21436. J Med Internet Res. 2020. PMID: 33284131 Free PMC article. Clinical Trial.
-
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27. Circulation. 2025. PMID: 39866113 Review.
-
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30. J Am Coll Cardiol. 2024. PMID: 38043043 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
